214 related articles for article (PubMed ID: 18458247)
1. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
McMahon PM; Kong CY; Johnson BE; Weinstein MC; Weeks JC; Kuntz KM; Shepard JA; Swensen SJ; Gazelle GS
Radiology; 2008 Jul; 248(1):278-87. PubMed ID: 18458247
[TBL] [Abstract][Full Text] [Related]
2. CT screening for lung cancer: five-year prospective experience.
Swensen SJ; Jett JR; Hartman TE; Midthun DE; Mandrekar SJ; Hillman SL; Sykes AM; Aughenbaugh GL; Bungum AO; Allen KL
Radiology; 2005 Apr; 235(1):259-65. PubMed ID: 15695622
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening outcomes.
Reich JM
Radiology; 2009 Oct; 253(1):277. PubMed ID: 19789261
[No Abstract] [Full Text] [Related]
5. Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.
Kong CY; Lee JM; McMahon PM; Lowry KP; Omer ZB; Eisenberg JD; Pandharipande PV; Gazelle GS
Radiology; 2012 Mar; 262(3):977-84. PubMed ID: 22357897
[TBL] [Abstract][Full Text] [Related]
6. National lung screening trial: variability in nodule detection rates in chest CT studies.
Pinsky PF; Gierada DS; Nath PH; Kazerooni E; Amorosa J
Radiology; 2013 Sep; 268(3):865-73. PubMed ID: 23592767
[TBL] [Abstract][Full Text] [Related]
7. Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.
Wang Z; Han W; Zhang W; Xue F; Wang Y; Hu Y; Wang L; Zhou C; Huang Y; Zhao S; Song W; Sui X; Shi R; Jiang J
Chin J Cancer; 2017 Jul; 36(1):57. PubMed ID: 28709441
[TBL] [Abstract][Full Text] [Related]
8. Population impact of lung cancer screening in the United States: Projections from a microsimulation model.
Criss SD; Sheehan DF; Palazzo L; Kong CY
PLoS Med; 2018 Feb; 15(2):e1002506. PubMed ID: 29415013
[TBL] [Abstract][Full Text] [Related]
9. Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations.
Patz EF; Swensen SJ; Herndon JE
J Clin Oncol; 2004 Jun; 22(11):2202-6. PubMed ID: 15169809
[TBL] [Abstract][Full Text] [Related]
10. Screening for lung cancer. The Mayo Lung Project revisited.
Flehinger BJ; Kimmel M; Polyak T; Melamed MR
Cancer; 1993 Sep; 72(5):1573-80. PubMed ID: 8394199
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
12. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
13. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme.
Felix L; Serra-Tosio G; Lantuejoul S; Timsit JF; Moro-Sibilot D; Brambilla C; Ferretti GR
Eur J Radiol; 2011 Mar; 77(3):410-6. PubMed ID: 19804950
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening with CT: Mayo Clinic experience.
Swensen SJ; Jett JR; Hartman TE; Midthun DE; Sloan JA; Sykes AM; Aughenbaugh GL; Clemens MA
Radiology; 2003 Mar; 226(3):756-61. PubMed ID: 12601181
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
18. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis.
Marcus PM; Bergstralh EJ; Zweig MH; Harris A; Offord KP; Fontana RS
J Natl Cancer Inst; 2006 Jun; 98(11):748-56. PubMed ID: 16757699
[TBL] [Abstract][Full Text] [Related]
19. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography.
Chien CR; Chen TH
Int J Cancer; 2008 Jun; 122(11):2594-9. PubMed ID: 18302157
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy.
de Hoop B; van Ginneken B; Gietema H; Prokop M
Radiology; 2012 Nov; 265(2):611-6. PubMed ID: 22929331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
